Risk is an inevitable aspect of medical care with recent studies illustrating the potential harm that can be done to patients using diclofenac with a cardiac history and codeine in paediatric patients. These studies apply in both cases to small subsets of each population however the implications have led health care bodies into disarray with the result that a large number of patients are no longer able to avail of these useful painkillers due to nationwide bans resulting in longer hospital stays and patients discharged on control drugs.
The background to the change in regulation of these two drugs is highlighted by The Medicines and Healthcare Products Regulatory Agency (MHRA) who have stated that diclofenac should not be used by people with underlying heart conditions or hypertension due to an increased risk of myocardial infarction and stroke 1 . The use of codeine in children and adolescents has also been restricted after a European safety review was triggered by case reports of children who received codeine after tonsillectomy for obstructive sleep apnoea (OSA) and developed rare, but life-threatening adverse events 2 .
A report, published in 2012, documented the cases of three children who died after receiving treatment with codeine after tonsillectomy 3 . Although the number of documented cases of codeine-related deaths remains small, the complications and legal outcomes of tonsillectomy malpractice claims found that the incidence of codeine-related deaths was much higher than expected. Using data from the Lexis Nexis Mega Jury Verdicts and Settlements database from 1984-2010 it was found that 18 percent of death claims and 5 percent of injury claims resulted from the use of opioids rather than haemorrhage which would be expected 4 .
Both medications are routinely used post operatively following a wide range of procedures in many specialities. While many of these patients are often well those with IHD other cardiovascular illnesses are encountered. Given the prevalence of children with OSA being less than 0.7% and those with CYP2D6 enzyme abnormalities (linked to abnormal codeine metabolism) being even less these patients are rarely encountered 5 .
Our patients' interest are first and foremost and providing them with adequate pain relief following surgical procedures is vitally important. Unfortunately we have blanketing guidelines which fail to take into account the low risk to most patients and certainly fail to take into account both medical expertise and patient choice and sensibility. Antiphospholipid antibody syndrome (APS) is traditionally characterized by the presence of circulating antiphospholipid antibodies (aPL) that lead to an increased risk of thrombosis and pregnancy morbidity. 1,2 Considered rare, diffuse alveolar hemorrhage (DAH) is thought to be a non-thrombotic manifestation of APS, likely secondary to aPL induced pulmonary capillaritis. 3 The diagnosis needs to be considered even in the absence of known thrombosis, as multiple recent case reports have identified DAH as the presenting symptom. Although APS is traditionally defined by strict diagnostic criteria, recent literature supports the pathogenic role of APS in many non-thrombotic disease states. 5 Non-criteria manifestations of APL include livedo reticularis, cardiac valve disease, thrombocytopenia, non-thrombotic neurologic manifestations, and nephropathy. Given our patient's thrombocytopenia, recently diagnosed seizure disorder, and positive aPL on two occasions, a diagnosis of probable APS was made. Her valvular disease was not considered diagnostic, as while APS is a known cause of Libman-Sacks endocarditis, it typically causes regurgitant mitral valve lesions rather than stenosis, consistent with the previous diagnosis of rheumatic heart disease.
APS may occur as an independent disease entity -primary APS -or in the setting of an underlying disease, usually SLE. In our patient, comorbid SLE is suspected given the presence of anti-dsDNA antibodies, lymphopenia, and recurrent idiopathic seizure.
Given the morbidity of DAH, the high-risk of recurrence, and the suspected underlying SLE, the patient has been managed with cyclophosphamide and hydroxychloroquine. Her inflammatory markers have normalized and she has had no subsequent disease flare. 
WhAT becoMes of The broken nose?
Editor, Nasal fractures are the most common facial injury, frequently associated with aesthetic, functional and psychological complications Seventy percent of patients with fractured nasal bones were male with an average age of 31 years, of which approximately 50 percent sustained nasal injury secondary to alleged assault. SIMON (Single, Immature, Male, Overly expectant and Narcissistic) is an acronym commonly used to identify patients who are likely to be unsatisfied with the outcome of nasal surgery 2 . We appear to be seeing an increasing number of patients fitting the SIMON criteria who are 'unsatisfied' with the outcomes of a procedure that in general provides satisfactory results. Alternatively there maybe a legal motivation for those pursuing open surgery considering that almost half of our patients reported injury secondary to alleged assault 3 .
Complex nasal injuries are frequently associated with high failure rates, following closed reduction of fractured nasal bones. These include grade III fractures involving the nasal septum and patients with previous nasal fractures 1, 4, 5 . Septal involvement is frequently underestimated by physicians when assessing and managing nasal fractures 1, 4, 5 . Our study showed many discrepancies between findings documented at the time of clinic compared to at the time of theatre, particularly in relation to the nasal septum. If closed reduction of fractured nasal bones is conducted without addressing a septal fracture, the septum will in time move the nasal bones back towards their deviated position 1, 4, 5 . Moreover, our results showed that approximately 25 percent of patients who had an unsatisfactory outcome reported previous nasal fractures.
Fractured nasal bones are successfully treated by closed reduction in the vast majority of cases, however a rising number of patients are now undergoing open surgery. We believe the reason for this increasing trend is multifactorial. Our results suggest that there is an increasing number of SIMONs within our society who are frequently unsatisfied with the result of cosmetic surgery or surgery following assault or injury. Furthermore factors such as status of the nasal septum and previous nasal injuries have to be considered if initial treatment is to be successful. Finally it is the authors experience that increasing numbers of patients with nasal fractures are being booked for septorhinoplasty at the outset rather than nasal bone manipulation if this is felt acceptable at the time of consultation and we predict that this trend will continue.
